The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: A randomized, controlled, open-label study

Scientific Reports
Da Young LeeCheol-Young Park

Abstract

This randomized, controlled, open-label study conducted in Kangbuk Samsung Hospital evaluated the effectiveness, reproducibility, and durability of tailored mobile coaching (TMC) on diabetes management. The participants included 148 Korean adult policyholders with type 2 diabetes divided into the Intervention-Maintenance (I-M) group (n = 74) and Control-Intervention (C-I) group (n = 74). Intervention was the addition of TMC to typical diabetes care. In the 6-month phase 1, the I-M group received TMC, and the C-I group received their usual diabetes care. During the second 6-month phase 2, the C-I group received TMC, and the I-M group received only regular information messages. After the 6-month phase 1, a significant decrease (0.6%) in HbA1c levels compared with baseline values was observed in only the I-M group (from 8.1 ± 1.4% to 7.5 ± 1.1%, P < 0.001 based on a paired t-test). At the end of phase 2, HbA1c levels in the C-I group decreased by 0.6% compared with the value at 6 months (from 7.9 ± 1.5 to 7.3 ± 1.0, P < 0.001 based on a paired t-test). In the I-M group, no changes were observed. Both groups showed significant improvements in frequency of blood-glucose testing and exercise. In conclusion, addition of TMC to convent...Continue Reading

References

Feb 1, 1991·Journal of Behavioral Medicine·M P CareyA W Meisler
May 2, 2001·The Cochrane Database of Systematic Reviews·C M RendersW J Assendelft
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotS E Skovlund
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Oct 19, 2010·International Journal of Nursing Studies·Eun Jin ChoiSang Hui Chu
Nov 17, 2010·Archives of Otolaryngology--head & Neck Surgery·Abie H MendelsohnMaie A St John
Jan 11, 2011·Diabetes Care·Boris P KovatchevLinda Gonder-Frederick
Oct 1, 2011·Current Diabetes Reports·Shelagh A MulvaneyLindsay Bosslet
Nov 24, 2011·Diabetes & Metabolism Journal·Seung-Hyun KoUNKNOWN Committee of Clinical Practice Guidelines, Korean Diabetes Association
Dec 12, 2012·JAMA Internal Medicine·Bonnie SpringDonald Hedeker
Apr 26, 2013·The New England Journal of Medicine·Mohammed K AliEdward W Gregg
Oct 3, 2013·American Journal of Hypertension·Alan L HinderliterJames A Blumenthal
Nov 15, 2013·Journal of Medical Internet Research·Morwenna KirwanMitch J Duncan
May 2, 2014·Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society·Eun-Hyun LeeSeung Jin Han
May 31, 2014·Journal of Diabetes Science and Technology·Kayo WakiKazuhiko Ohe
Jul 9, 2014·Diabetes & Metabolism Journal·Ja Young JeonUNKNOWN Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association
Aug 8, 2014·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Charlene C QuinnAnn L Gruber-Baldini
Feb 18, 2015·Journal of Public Health·Sheikh Mohammed Shariful IslamLouis W Niessen
Oct 16, 2015·Current Diabetes Reports·Laura F GarabedianJ Frank Wharam
Feb 9, 2017·Frontiers in Endocrinology·Arun ChaudhuryWasique Mirza

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03033407

Software Mentioned

R
iOS
Switch

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.